Literature DB >> 2049241

The validity of the sigmoid Emax model and efficiency concept in diuretic studies.

G Alván, M Hammarlund-Udenaes, B Odlind.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 2049241      PMCID: PMC1368398          DOI: 10.1111/j.1365-2125.1991.tb05520.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Use of Emax model in diuretic studies.

Authors:  F H Noormohamed
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

2.  Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man.

Authors:  J G Wagner
Journal:  J Theor Biol       Date:  1968-08       Impact factor: 2.691

3.  On the mechanism of acute tolerance to furosemide diuresis.

Authors:  P A Sjöström; B G Odlind; B A Beermann; M Hammarlund-Udenaes
Journal:  Scand J Urol Nephrol       Date:  1988

4.  The time course of delivery of furosemide into urine: an independent determinant of overall response.

Authors:  S Kaojarern; B Day; D C Brater
Journal:  Kidney Int       Date:  1982-07       Impact factor: 10.612

5.  Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.

Authors:  M M Hammarlund; B Odlind; L K Paalzow
Journal:  J Pharmacol Exp Ther       Date:  1985-05       Impact factor: 4.030

6.  Diuretic effect and diuretic efficiency after intravenous dosage of frusemide.

Authors:  G Alván; L Helleday; A Lindholm; E Sanz; T Villén
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

Review 7.  Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.

Authors:  M Hammarlund-Udenaes; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1989-02
  7 in total
  3 in total

Review 1.  The efficiency concept in pharmacodynamics.

Authors:  G Alván; G Paintaud; M Wakelkamp
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

2.  Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.

Authors:  G Alván; G Paintaud; S A Eckernäs; A Grahnén
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

3.  Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency.

Authors:  R W van Olden; J J van Meyel; P G Gerlag
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.